Insulin glargine safety in pregnancy: A transplacental transfer study

Diabetes Care

Volumn 33, Issue 1, 2010, Pages 29-33

  Pollex, Erika K ^a,b   Feig, Denice S ^c   Lubetsky, Angelika ^a   Yip, Paul M ^c   Koren, Gideon ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN GLARGINE;

ARTICLE; BLOOD PLACENTA BARRIER; CESAREAN SECTION; CHEMOLUMINESCENCE; CONTINUOUS INFUSION; DRUG SAFETY; FETUS CIRCULATION; HUMAN; HUMAN TISSUE; IMMUNOASSAY; PLACENTAL TRANSFER; PREGNANCY;

BIOLOGICAL TRANSPORT; FEMALE; FETAL BLOOD; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MATERNAL-FETAL EXCHANGE; PERFUSION; PLACENTA; PREGNANCY;

EID: 74249107242     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-1045     Document Type: Article

References (25)

1. 125I labelled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites. Diabetes Care 2000;23:813-819
2. Plank J, Bodenlenz M, Sinner F, Magnes C, Görzer E, Regittnig W, Endahl LA, Draeger E, Zdravkovic M, Pieber TR. A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir. Diabetes Care 2005;28:1107-1112
3. Gough SC. A review of human and analogue insulin trials. Diabetes Res Clin Pract 2007;77:1-15
4. Yki-Järvinen H, Dressler A, Ziemen M; the HOE901/300s Study Group. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes: HOE 901/3002 study group. Diabetes Care 2000;23:1130-1136
5. Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care 2005;28:950-955
6. Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, Zigrang WD. Preconception care of diabetes: glycemic control prevents congenital anomalies. JAMA 1991;265:731-736
7. Mello G, Parretti E, Mecacci F, Pratesi M, Lucchetti R, Scarselli G. Excursion of daily glucose profiles in pregnant women with IDDM: relationship with perinatal outcome. J Perinat Med 1997;25:488-497
8. Mello G, Parretti E, Mecacci F, La Torre P, Cioni R, Cianciulli D, Scarselli G. What degree of maternal metabolic control in women with type 1 diabetes is associated with normal body size and proportions in full-term infants? Diabetes Care 2000;23:1494-1498
9. Jovanovic-Peterson L, Peterson CM, Reed GF, Metzger BE, Mills JL, Knopp RH, Aarons JH. Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development-Diabetes in Early Pregnancy Study. Am J Obstet Gynecol 1991;164:103-111
10. Kitzmiller JL, Block JM, Brown FM, Catalano PM, Conway DL, Coustan DR, Gunderson EP, Herman WH, Hoffman LD, Inturrisi M, Jovanovic LB, Kjos SI, Knopp RH, Montoro MN, Ogata ES, Paramsothy P, Reader DM, Rosenn BM, Thomas AM, Kirkman MS. Managing preexisting diabetes for pregnancy; summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060-1079
11. Rosenn BM, Miodovnik M, Holcberg G, Khoury JC, Siddiqi TA. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet Gynecol 1995;85:417-422
12. Campbell RK, White JR, Levien T, Baker D. Insulin glargine. Clin Ther 2001;23:1938-1957; discussion 1923
13. Menon RK, Cohen RM, Sperling MA, Cutfield WS, Mimouni F, Khoury JC. Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus: its role in fetal macrosomia. N Engl J Med 1990;323:309-315
14. Duckworth WC, Bennett RG, Hamel FG. Insulin degradation: progress and potential. Endocr Rev 1998;19:608-624
15. Kurtzhals P, Schäffer L, Sørensen A, Kristensen C, Jonassen I, Schmid C, Trüb T. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 2000;49:999-1005
16. Ciaraldi TP, Phillips SA, Carter L, Aroda V, Mudaliar S, Henry RR. Effects of the rapid-acting insulin analogue insulin glargine on cultured human skeletal muscle cells: comparisons to insulin and insulin-like growth factor-1. J Clin Endocrinol Metab 2005;86:5838-5847
17. Gallen IW, Jaap A, Roland JM, Chirayath HH. Survey of glargine use in 115 pregnant women with type 1 diabetes. Diabet Med 2008;25:165-169
18. Imbergamo MP, Amato MC, Sciortino G, Gambina M, Accidenti M, Criscimanna A, Giordano C, Galluzzo A. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study. Clin Ther 2008;30:1476-1484
19. Pöyhönen-Alho M, Rönnemaa T, Saltevo J, Ekblad U, Kaaja RJ. Use of insulin glargine during pregnancy. Acta Obstet Gynecol Scand 2007;86:1171-1174
20. Price N, Bartlett C, Gillmer M. Use of insulin glargine during pregnancy: a case-control pilot study. BJOG 2007;114:453-457
21. Derewlany LO, Leeder JS, Kumar R, Radde IC, Knie B, Koren G. The transport of digoxin across the perfused human placental lobule. J Pharmacol Exp Ther 1991;256:1107-1111
22. Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di Vincenzo A, Cordoni C, Costa E, Brunetti P, Bolli GB. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 2000;49:2142-2148
23. Moriyama M, Hayashi N, Ohyabu C, Mukai M, Kawano S, Kumagai S. Performance evaluation and cross-reactivity from insulin analogs with the ARCHITECT insulin assay. Clin Chem 2006;52:1423-1426
24. Steel RB, Mosley JD, Smith CH. Insulin and placenta: degradation and stabilization, binding to microvillous membrane receptors, and amino acid uptake. Am J Obstet Gynecol 1979;135:522-529
25. Kuerzel GU, Shukla U, Scholtz HE, Pretorius SG, Wessels DH, Venter C, Potgieter MA, Lang AM, Koose T, Bernhardt E. Biotransformation of insulin glargine after subcutaneous injection in healthy subjects. Curr Med Res Opin 2003;19:34-40